mycobacterium tuberculosis mtb genomic dna (ATCC)
Structured Review
Mycobacterium Tuberculosis Mtb Genomic Dna, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mycobacterium+tuberculosis+mtb/Mycobacterium+tuberculosis%3B+genomic+DNA/pmc12943657-49-59-64
Average 93 stars, based on 11 article reviews
Images
Related Articles
In Vitro:Article Title: Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential Liabilities. Article Snippet: Linezolid is a drug with proven human antitubercular activity whose use is limited to highly drug-resistant patients because of its toxicity.. This toxicity is related to its mechanism of action�linezolid inhibits protein synthesis in both bacteria and eukaryotic mitochondria.. A highly selective and potent series of oxazolidinones, bearing a 5-aminomethyl moiety (in place of the typical 5-acetamidomethyl moiety of linezolid), was identified. Activity Assay:Article Title: New silver(I) phosphino complexes: Evaluation of their potential as prospective agents against Mycobacterium tuberculosis. Article Snippet: Despite being a preventable and curable disease, Tuberculosis (TB) is the world's top infectious killer.. Development of new drugs is urgently needed.. In this work, the synthesis and characterization of new silver(I) complexes, that include N-[(E)-(pyridine-2-ylmethylene)pyrazine-2-carbohydrazide, HPCPH, as main ligand and substituted aryl-phosphines as auxiliary ligands, is reported. Article Title: Medicinal Perspective of 2,4-Thiazolidinediones Derivatives: An Insight into Recent Advancements. Article Snippet: .. The synthesized compounds underwent investigation for their antitubercular activity against Mycobacterium bovis BCG (ATCC 35743) and Article Title: Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements Article Snippet: .. The synthesized compounds underwent investigation for their antitubercular activity against Mycobacterium bovis BCG (ATCC 35743) and Drug discovery:Article Title: New silver(I) phosphino complexes: Evaluation of their potential as prospective agents against Mycobacterium tuberculosis. Article Snippet: Despite being a preventable and curable disease, Tuberculosis (TB) is the world's top infectious killer.. Development of new drugs is urgently needed.. In this work, the synthesis and characterization of new silver(I) complexes, that include N-[(E)-(pyridine-2-ylmethylene)pyrazine-2-carbohydrazide, HPCPH, as main ligand and substituted aryl-phosphines as auxiliary ligands, is reported. Synthesized:Article Title: Medicinal Perspective of 2,4-Thiazolidinediones Derivatives: An Insight into Recent Advancements. Article Snippet: .. The synthesized compounds underwent investigation for their antitubercular activity against Mycobacterium bovis BCG (ATCC 35743) and Article Title: Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements Article Snippet: .. The synthesized compounds underwent investigation for their antitubercular activity against Mycobacterium bovis BCG (ATCC 35743) and Cell Culture:Article Title: Compromised Metabolic Reprogramming Is an Early Indicator of CD8 + T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection Article Snippet: .. |

